PeptiLux Hub: Peptide Science 🔬✨

Researchers developed potent G protein pathway-biased GPR183 agonists, which may modulate lymphoid cell localization and inflammation-associated diseases. 💡 Why it matters: The development of GPR183 agonists is relevant to peptide and biotech research due to its potential therapeutic applications. 💭 Discussion: How might GPR183 agonists impact the treatment of inflammation-associated diseases? 🔗 https://www.biorxiv.org/content/10.64898/2026.07.27.740726v1?rss=1 #PeptideResearch